Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Gruppo Italiano Malattie Ematologiche Dell'adulto

Clinical trials sponsored by Gruppo Italiano Malattie Ematologiche Dell'adulto, explained in plain language.

Trials to join now! 2 Not yet recruiting 6 Not yet finished but already full! 6 Completed 1
Sort by
  • New study investigates why some AML patients face early bleeding or clotting risks

    Knowledge-focused Recruiting now

    This observational study examines a specific group of patients with a type of acute myeloid leukemia (AML) that has an NPM1 mutation. Researchers want to see if a particular subset, called APL-like, is linked to early blood vessel problems like bleeding or clots. The study will l…

    Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused

    Last updated Jun 27, 2026 14:01 UTC

  • Real-World data on SVd combo for myeloma: will it hold up outside trials?

    Knowledge-focused Recruiting now

    This observational study is collecting information on how well the combination of selinexor, bortezomib, and dexamethasone (SVd) works for adults with multiple myeloma who have already tried 1 to 3 other treatments. Researchers will track 159 patients for about 3 years to see how…

    Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused

    Last updated Jun 26, 2026 16:53 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space